• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈上皮内瘤变患者高危型人乳头瘤病毒持续感染的危险因素

Risk factors for persistent infection of high-risk HPV in patients with cervical intraepithelial neoplasia.

作者信息

Wang Juan, Tian Zan, Wang Jiaomin

机构信息

Department of Obstetrics and Gynecology, Tongzhou Maternal and Child Health Hospital of Beijing Beijing 101100, China.

Department of Medicine, Tongzhou Maternal & Child Health Hospital of Beijing Beijing 101100, China.

出版信息

Am J Transl Res. 2025 Apr 15;17(4):2992-3000. doi: 10.62347/GGVR2248. eCollection 2025.

DOI:10.62347/GGVR2248
PMID:40385069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082543/
Abstract

OBJECTIVE

To identify the risk factors for persistent HR-HPV infection in patients with cervical intraepithelial neoplasia (CIN).

METHODS

A total of 312 patients with cervical intraepithelial neoplasia were followed up for six months. Among them, 164 patients with persistent HPV infection during re-examination were categorized into the persistent infection group, while 148 patients with negative HPV results were classified into the negative conversion group.

RESULTS

Multivariate logistic regression analyses identified the following independent risk factors for persistent HR-HPV infection: age ≥50 years (95% CI: 3.037-11.447; P<0.001), multiple HPV infections (95% CI: 4.250-18.417; P<0.001), HPV viral load ≥100 (95% CI: 1.529-5.673; P=0.001), reproductive tract inflammation (95% CI: 1.186-4.696; P=0.014), and thyroid dysfunction (95% CI: 8.346-17.207; P<0.001). A prediction model was developed based on the logistic regression analysis: Logit(P) = -102.56 + (age × 1.774) + (HPV multiple infections × 2.180) + (HPV viral load ≥100 × 1.080) + (reproductive tract inflammation × 0.859) + (thyroid dysfunction × 3.650). Receiver operating characteristic (ROC) curve analysis showed an area under the curve (AUC) of 0.800 for the model in predicting persistent high-risk HPV infection, with sensitivity of 81.00% and specificity of 79.46%.

CONCLUSION

Age ≥50 years, multiple HPV infections, HPV viral load ≥100, reproductive tract inflammation, and thyroid dysfunction are independent risk factors for persistent high-risk HPV infection in patients with CIN.

摘要

目的

确定宫颈上皮内瘤变(CIN)患者持续性高危型人乳头瘤病毒(HR-HPV)感染的危险因素。

方法

对312例宫颈上皮内瘤变患者进行为期6个月的随访。其中,复查时164例HPV持续感染患者被归入持续感染组,148例HPV结果为阴性的患者被归入转阴组。

结果

多因素logistic回归分析确定了以下持续性HR-HPV感染的独立危险因素:年龄≥50岁(95%置信区间:3.037 - 11.447;P<0.001)、多种HPV感染(95%置信区间:4.250 - 18.417;P<0.001)、HPV病毒载量≥100(95%置信区间:1.529 - 5.673;P = 0.001)、生殖道炎症(95%置信区间:1.186 - 4.696;P = 0.014)以及甲状腺功能障碍(95%置信区间:8.346 - 17.207;P<0.001)。基于logistic回归分析建立了一个预测模型:Logit(P) = -102.56 +(年龄×1.774)+(HPV多种感染×2.180)+(HPV病毒载量≥100×1.080)+(生殖道炎症×0.859)+(甲状腺功能障碍×3.650)。受试者工作特征(ROC)曲线分析显示,该模型预测持续性高危型HPV感染的曲线下面积(AUC)为0.800,灵敏度为81.00%,特异度为79.46%。

结论

年龄≥50岁、多种HPV感染、HPV病毒载量≥100、生殖道炎症以及甲状腺功能障碍是CIN患者持续性高危型HPV感染的独立危险因素。

相似文献

1
Risk factors for persistent infection of high-risk HPV in patients with cervical intraepithelial neoplasia.宫颈上皮内瘤变患者高危型人乳头瘤病毒持续感染的危险因素
Am J Transl Res. 2025 Apr 15;17(4):2992-3000. doi: 10.62347/GGVR2248. eCollection 2025.
2
Correlation Between Persistent HPV Infection and Vaginal Microecological Imbalance After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.宫颈高级别鳞状上皮内病变治疗后 HPV 持续感染与阴道微生态失衡的相关性。
Altern Ther Health Med. 2024 Jan;30(1):414-418.
3
Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.高危型人乳头瘤病毒感染无宫颈病变的结局及其相关因素。
BMC Womens Health. 2023 Nov 14;23(1):599. doi: 10.1186/s12905-023-02764-8.
4
[Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].高危型人乳头瘤病毒DNA载量与不同组织学分级宫颈肿瘤之间的关联
Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jul;43(7):565-70.
5
Role of Cyclooxygenase-2 (COX-2) Expression as a Prediction of Persistent Cervical Low Grade Squamous Intraepithelial Lesion (LSIL).环氧化酶-2(COX-2)表达在预测持续性宫颈低度鳞状上皮内病变(LSIL)中的作用。
Asian Pac J Cancer Prev. 2025 Mar 1;26(3):791-797. doi: 10.31557/APJCP.2025.26.3.791.
6
Distribution and diagnostic value of single and multiple high-risk HPV infections in detection of cervical intraepithelial neoplasia: A retrospective multicenter study in China.在中国一项回顾性多中心研究中,单一和多种高危型 HPV 感染在检测宫颈上皮内瘤变中的分布及诊断价值。
J Med Virol. 2024 Aug;96(8):e29835. doi: 10.1002/jmv.29835.
7
Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.特定型别的人乳头瘤病毒与其他因素对宫颈上皮内瘤变风险的影响:韩国的一项病例对照研究。
Int J Gynecol Cancer. 2010 Aug;20(6):1067-73. doi: 10.1111/IGC.0b013e3181e4a720.
8
Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia.宫颈上皮内瘤变合并阴道上皮内瘤变患者的临床特征、HPV 感染及人口统计学危险因素。
BMC Womens Health. 2024 Apr 4;24(1):220. doi: 10.1186/s12905-024-03030-1.
9
Factors affecting residual/recurrent cervical intraepithelial neoplasia after cervical conization with negative margins.影响宫颈锥切术后阴性切缘的宫颈上皮内瘤变残留/复发的因素。
J Med Virol. 2018 Sep;90(9):1541-1548. doi: 10.1002/jmv.25208. Epub 2018 May 25.
10
Evaluation of the efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy in women with high-risk HPV persistent infection after cervical conization.宫颈锥切术后高危型人乳头瘤病毒持续感染女性中5-氨基酮戊酸介导的光动力疗法的疗效和安全性评估
Photodiagnosis Photodyn Ther. 2022 Dec;40:103144. doi: 10.1016/j.pdpdt.2022.103144. Epub 2022 Oct 6.

引用本文的文献

1
Investigation of the Prevalence of High-Risk Human Papillomavirus, Human Herpesvirus-8, and Herpes Simplex Virus-2 in Cervical Biopsy Samples Using the Real-Time PCR Method.使用实时聚合酶链反应法对宫颈活检样本中高危型人乳头瘤病毒、人疱疹病毒8型和单纯疱疹病毒2型的流行情况进行调查。
Trop Med Infect Dis. 2025 Jul 17;10(7):200. doi: 10.3390/tropicalmed10070200.

本文引用的文献

1
Genetic defects of brain immunity in childhood herpes simplex encephalitis.儿童单纯疱疹脑炎的脑免疫遗传缺陷。
Nature. 2024 Nov;635(8039):563-573. doi: 10.1038/s41586-024-08119-z. Epub 2024 Nov 20.
2
Post-conization pathological upgrading and outcomes of 466 patients with low-grade cervical intraepithelial neoplasia.466例低级别宫颈上皮内瘤变患者锥切术后的病理升级及结局
Front Oncol. 2024 Sep 11;14:1449080. doi: 10.3389/fonc.2024.1449080. eCollection 2024.
3
Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential.宫颈阴道微生物组、高危型 HPV 感染与宫颈癌:机制与治疗潜力。
Microbiol Res. 2024 Oct;287:127857. doi: 10.1016/j.micres.2024.127857. Epub 2024 Jul 26.
4
Endometriosis Typology and Ovarian Cancer Risk.子宫内膜异位症的分型与卵巢癌风险。
JAMA. 2024 Aug 13;332(6):482-489. doi: 10.1001/jama.2024.9210.
5
Sequential immunotherapy: towards cures for autoimmunity.序贯免疫疗法:走向自身免疫病的治愈之路。
Nat Rev Drug Discov. 2024 Jul;23(7):501-524. doi: 10.1038/s41573-024-00959-8. Epub 2024 Jun 5.
6
Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.人乳头瘤病毒感染:流行病学、生物学、宿主相互作用、癌症发展、预防和治疗。
Rev Med Virol. 2024 May;34(3):e2537. doi: 10.1002/rmv.2537.
7
Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions.宫颈病变中人类乳头瘤病毒基因型分布与流行情况的综合概述
Gynecol Obstet Clin Med. 2024 Apr;4(1). doi: 10.1136/gocm-2024-000005.
8
A break in mitochondrial endosymbiosis as a basis for inflammatory diseases.线粒体内共生中断作为炎症性疾病的基础。
Nature. 2024 Feb;626(7998):271-279. doi: 10.1038/s41586-023-06866-z. Epub 2024 Feb 7.
9
Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review.西妥昔单抗治疗颈恶性肿瘤致急性视网膜坏死 1 例并文献复习
Front Immunol. 2024 Jan 23;15:1301329. doi: 10.3389/fimmu.2024.1301329. eCollection 2024.
10
Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation.化学免疫宫颈锥形切除术治疗癌前病变可激活免疫细胞,恢复 HPV 阴性和异常增殖正常。
Front Immunol. 2024 Jan 3;14:1259723. doi: 10.3389/fimmu.2023.1259723. eCollection 2023.